| abstract |
The compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein said compounds have the structure of formula (I) wherein R, R, R and R are as defined in the description of the invention. Relevant pharmaceutical compositions, methods of treatment, methods of synthesis and intermediates are also disclosed. |